Qnostics

Molecular controls for infectious disease testing

Request a quote

Leading Quality Control Solutions

Qnostics is a leading provider of Quality Control solutions for Molecular Infectious Disease testing. Designed to meet the demands of today’s molecular diagnostics laboratory and laboratories carrying out Nucleic Acid Testing (NAT), our range comprises hundreds of characterised viral, bacterial and fungal targets covering a wide range of Transplant Associated Diseases, Respiratory Diseases, Blood Borne Viruses, Sexually Transmitted Infections, Gastrointestinal Infections and Central Nervous System Diseases.

SARS-CoV-2
(COVID-19) Control

Qnostics SARS-CoV-2 (COVID-19) Control

Accurate and reliable COVID-19 laboratory testing. In response to the current Coronavirus outbreak, Qnostics, a world-leading manufacturer of QC solutions for molecular infectious disease testing, has developed a SARS-CoV-2 control designed for use alongside molecular assays used in the testing of COVID-19. Accurate and reliable laboratory testing is an essential aspect of COVID-19 disease management and outbreak control. The use of a third-party quality control will allow diagnostic laboratories to effectively monitor the performance of diagnostic methods.

Get started
  • Whole Pathogen Control
    Contains the entire SARS CoV-2 genome meaning it is compatible with the majority of commercial & in-house assays targeting the CDC and WHO consensus sequences.
  • Full Process Control
    Designed to mimic the patient sample, full process controls will effectively monitor the performance of the entire testing process from extraction to amplification and detection.
  • Highly Characterized
    Controls quantified by digital PCR ensuring batch to batch reproducibility.

Blood Borne Virus (BBV)
Q Controls

Blood Borne Virus (BBV) Q Controls

Whole pathogen and manufactured independently, our Qnostics Blood Borne Virus (BBV) Controls are designed to monitor the daily performance of molecular methods.  

The target pathogens of primary concern are Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) – these pathogens are supplied in single packs and the concentration of each positive sample is designed to be within the dynamic range.

Get started
  • Whole pathogen controls designed to monitor the entire testing process 
  • Liquid frozen for user convenience and ease of use 
  • Suitable for use with a wide range of commercial and in-house molecular methods 
  • Traceable to international standards (where available) or to internal reference material 
  • All controls are manufactured to ISO 13485: 2016 standards  

Respiratory Triplex
Q Control

Respiratory Triplex Q Control

Monitor the daily performance of detection methods for key viruses. Whole pathogen and manufactured independently, the Respiratory Triplex Q Control is designed to monitor the daily performance of molecular methods used in the detection of Influenza A, Influenza B and Respiratory Syncytial Virus A (RSV A).  

Five positive and five negative samples are conveniently supplied in a single pack reducing the number of individual kits required. The target concentration of each of the positive samples is designed to be within the dynamic range of most molecular assays. 

Get started
  • Whole pathogen control designed to monitor the entire testing process 
  • Liquid frozen for user convenience and ease of use 
  • Consolidated triplex control delivering significant cost and time savings 
  • Suitable for use with a wide range of commercial and in-house molecular methods 
  • Manufactured to ISO 13485 quality standards